Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $55.99 in the prior trading day, Corcept Therapeutics Inc (NASDAQ: CORT) closed at $55.49, down -0.89%. In other words, the price has decreased by -$0.89 from its previous closing price. On the day, 1.23 million shares were traded.
Ratios:
Our goal is to gain a better understanding of CORT by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 29.88. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 3.35. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when Maduck Sean sold 18,303 shares for $60.69 per share. The transaction valued at 1,110,818 led to the insider holds 85,622 shares of the business.
Lyon Joseph Douglas sold 4,579 shares of CORT for $277,902 on Mar 03 ’25. The insider now owns 9,009 shares after completing the transaction at $60.69 per share. On Mar 04 ’25, another insider, Guyer William, who serves as the Chief Development Officer of the company, sold 20,000 shares for $59.07 each. As a result, the insider received 1,181,400 and left with 5,487 shares of the company.
Valuation Measures:
As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 45.00, and their Forward P/E ratio for the next fiscal year is 15.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.67 while its Price-to-Book (P/B) ratio in mrq is 8.58.
Stock Price History:
Over the past 52 weeks, CORT has reached a high of $75.00, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -7.16%, while the 200-Day Moving Average is calculated to be 21.66%.
Shares Statistics:
A total of 105.11M shares are outstanding, with a floating share count of 93.10M. Insiders hold about 11.76% of the company’s shares, while institutions hold 80.25% stake in the company.
